Health & Fitness
Health and Fitness
Health and Fitness
Tue, October 25, 2011
Mon, October 24, 2011
ZELTIQ Aesthetics, Inc. Completes Initial Public Offering
PLEASANTON, Calif.--([ BUSINESS WIRE ])--ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the closing of its initial public offering of 8,050,000 shares of common stock at a price of $13.00 per share. The amount sold includes 307,000 shares sold by selling stockholders. The shares began trading on October 19, 2011 on The NASDAQ Global Select Market under the ticker symbol "ZLTQ."
The Company raised net proceeds of approximately $89.3 million from the sale of 7,743,000 shares of its common stock. The Company did not receive any of the proceeds from the sale of the shares offered by the selling stockholders.
J.P. Morgan Securities LLC and Goldman, Sachs & Co. acted as joint book-running managers. William Blair & Company, LLC and Canaccord Genuity Inc. acted as co-managers.
ZELTIQ has filed a registration statement, including a prospectus, with the Securities and Exchange Commission, or the SEC, for the offering to which this communication relates. Before you invest, you should read the prospectus in the registration statement and other documents ZELTIQ has filed with the SEC for more complete information about ZELTIQ and this offering. You may obtain these documents for free by visiting the SEC website at [ www.sec.gov ]. Alternatively, ZELTIQ, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Ave., Edgewood, NY 11717 (Tel: 866-803-9204) or Goldman, Sachs & Co., Attn: Prospectus Department, 200 West Street, New York, NY 10282, (Tel: 866-471-2526), Email: [ prospectus-ny@ny.email.gs.com ].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. The Companyas first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise.
